U.S. Biotech Model Is “Recipe For Success” In Asia – BIO Senior Officials
This article was originally published in PharmAsia News
Executive Summary
Asian countries looking to develop their biotech industries should look to the U.S. model as a framework for structuring regulations, especially intellectual property regimes, senior officials at the U.S. Biotechnology Industry Organization said in an interview with PharmAsia News
You may also be interested in...
Thailand’s Ministers Of Health, Commerce And Foreign Affairs Conclude Compulsory Licensing Legal
PERTH, Australia - A plan by Thailand's new Public Health Minister Chaiya Sasomsab to review the country's policy on compulsory licensing for four cancer drugs has stalled again after three ministry officials said the policy could not be revoked, the Bangkok Post reported Feb. 20
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).